Comparative Trial of Operative Treatment of Distal Pediatric Forearm Fractures With Biodegradable Nails and K-wires

NCT ID: NCT04848818

Last Updated: 2021-04-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

164 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-03-01

Study Completion Date

2022-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study is designed as a multicenter trial for the treatment of distal pediatric forearm fractures (=severely displaced distal metaphyseal forearm fractures) with a PLGA-based biodegradable intramedullary implant in children. The primary objective of the trial is to evaluate clinical outcome between Activa IM-Nail™ and K-wire in this indication. The secondary objective is to evaluate potential differences of potential complications in the operative method with either a biodegradable intramedullary PLGA-implant or with conventional K-wires. K-wire osteosynthesis will be made according to the conventional surgical technique by three paediatric trauma centers. Intramedullary PLGA implantation will be made by the Péterfy Hospital. The surgical indication will be the same in all groups, and follow-up will follow standard protocols. In the further clinical course, the patients in the study group treated with PLGA implants spare a subsequent operation for implant removal after 4-8 weeks. The results of different surgeries will be compared based on several criteria.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Over the last decade, there has been an increasing demand to overcome the disadvantages associated with conventional implant materials, by developing new, alternative materials and material production approaches for use in trauma care.

In recent years there has been a growing interest in the orthopaedic application of resorbable implants. Their use in children may be particularly beneficial. Poly(L-lactide)-co-glycolide acid (PLGA) is a well-known, reliable biodegradable material that has been used in bone surgery for more than 20 years. Several publications have already reported the successful use of intra-medullar PLGA implants in the treatment of paediatric diaphyseal forearm fractures.

To gather further evidence about the clinical value of the new method with PLGA - based bioresorbable implant in regard to patients benefit, a multicenter prospective trial is needed. This trial will be conducted on the distal forearm, which is one of the most common fracture locations that requires surgical intervention in children. Severely displaced distal paediatric forearm fractures will be addressed.

Distal paediatric forearm injuries

Distal radius fractures are among the most common injuries of childhood. Optimal treatment for distal radius fractures is still controversial. Treatment of severely displaced and shortened fractures usually require general narcosis and closed reduction. Most authors recommend osteosynthesis if the fracture remains unstable after reduction. The gold standard operative method for these fractures is closed reduction, percutaneous pinning with Kirschner-wires.

Kirschner-wire related minor complications are relatively frequent. Migration of the pins, superficial infections, skin irritation are well manageable but significantly impair the child's sense of comfort. Deep infections, tendon or nerve injuries may occur less often. There is a controversy as to whether it is preferable to leave the wires outside the skin. While wires left out of the skin increase the risk of infection, wires buried under the skin can be removed with a second intervention. Removing the implants can also cause complications.

K-wires are not capable of providing sufficient stabilization in this indication, so additional casting treatment is also required. The duration and the type of postoperative immobilization varies greatly according to the practice of the surgeons. There is no evidence about the most optimal immobilization procedure. 4-6 weeks of cast wearing is recommended by most authors. This causes stiffness in the affected joints and delays the recovery of full function. Fractures with intramedullary elastic nails require a reduced time of immobilization because they provide a more stable synthesis, but nails can be removed only under general anaesthesia. The use of bioabsorbable intramedullary nails in distal paediatric forearm fractures may eliminate all of the above-mentioned disadvantages.

The study is designed as a multicenter trial for the treatment of distal pediatric forearm fractures (=severely displaced distal metaphyseal forearm fractures) with a PLGA-based biodegradable intramedullary implant in children. The primary objective of the trial is to evaluate clinical outcome between Activa IM-Nail™ and K-wire in this indication. The secondary objective is to evaluate potential differences of potential complications in the operative method with either a biodegradable intramedullary PLGA-implant or with conventional K-wires. K-wire osteosynthesis will be made according to the conventional surgical technique by two paediatric trauma centers. Intramedullary PLGA implantation will be made by the Péterfy Hospital. The surgical indication will be the same in all groups, and follow-up will follow standard protocols. In the further clinical course, the patients in the study group treated with PLGA implants spare a subsequent operation for implant removal after 4-8 weeks. The results of different surgeries will be compared based on several criteria.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Fracture Wrist

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

K-wire group

Children with closed or grade I. open, severly displaced distal radial and/or complete forearm metaphyseal fractures between the age 3-13.

Group Type ACTIVE_COMPARATOR

Distal radial metaphyseal fracture fixation with percutaneous K-wires

Intervention Type PROCEDURE

Pediatric distal metaphyseal fractures which are severly displaced will be operated with percutaneous K-wires..

Activa-IM Nail group

Children with closed or grade I. open, severly displaced distal radial and/or complete forearm metaphyseal fractures between the age 3-13.

Group Type ACTIVE_COMPARATOR

Distal radial and/or ulnar metaphyseal fracture fixation with bidegradable PLGA-based (Activa Im-Nail) implants

Intervention Type PROCEDURE

Pediatric distal metaphyseal radial and /or ulnar fractures which are severly displaced will be operated with percutaneous bidegradable PLGA-based (Activa Im-Nail) implants.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Distal radial metaphyseal fracture fixation with percutaneous K-wires

Pediatric distal metaphyseal fractures which are severly displaced will be operated with percutaneous K-wires..

Intervention Type PROCEDURE

Distal radial and/or ulnar metaphyseal fracture fixation with bidegradable PLGA-based (Activa Im-Nail) implants

Pediatric distal metaphyseal radial and /or ulnar fractures which are severly displaced will be operated with percutaneous bidegradable PLGA-based (Activa Im-Nail) implants.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Clinical diagnosis of distal radial or complete forearm fracture Metaphyseal radial/or distal forearm fractures with complete displacement and shortening.

Age between of 3-13 years. Open physeal plates on X-rays. Closed or Grade I. open fractures Ability and willingness to give an informed consent

Exclusion Criteria

Pathological fractures (e.g. bone cyst) Poly-traumatized patient Inability or unwillingness to give informed consent Closed physeal plates on X-rays. Active skin infection in the surgical area
Minimum Eligible Age

3 Years

Maximum Eligible Age

13 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Péterfy Sándor Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Marcell Varga, PhD

Role: PRINCIPAL_INVESTIGATOR

Péterfy Hospital, National Trauma Center,Budapest

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Szent János Hospital

Budapest, Diós Árok 1., Hungary

Site Status RECRUITING

Péterfy Hospital

Budapest, Fiumei Út 17, Hungary

Site Status RECRUITING

Medical University of Pécs, Pediatric Surgery

Pécs, József Attila U 7., Hungary

Site Status RECRUITING

Heim Pál Hospital

Budapest, Üllöi Út 86, Hungary

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Hungary

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Marcell Varga, PhD

Role: CONTACT

0036709323027

Tamás Kassai, MD

Role: CONTACT

003612997700

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

András Petrovics, MD

Role: primary

0036309817337

Tamás Mona, MD

Role: backup

0036209965234

Marcell Varga, PhD

Role: primary

0036709323027

Gergő Józsa, PhD

Role: primary

0036305142730

Rita Varga, MD

Role: primary

0036303306445

Zoltán Ringwald, MD

Role: backup

0036204032800

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

228-01-CIP-3

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.